Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the downfalls of the use of cell-free DNA in the detection of cancer at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.